As the Former EVP and General Counsel; Business Unit Lead, Consumer Healthcare at Pfizer, Amy Schulman earned a total compensation of $5,120,741 in 2013, which decreased by 8.12% compared to 2012.

Of this total, $952,750 was earned as salary, $1,529,600 was awarded as stock, $1,542,325 was received in stock options, $936,400 was awarded from non-equity incentive plan, and $159,666 came from all other compensation.

Ms. Schulman stepped down as a member of the ELT and as EVP & General Counsel; Business Unit Lead of Consumer Healthcare, effective December 16, 2013.

Amy Schulman worked with Olivier Brandicourt, John Young, Geno Germano, Mikael Dolsten, Frank D'Amelio, and Ian Read at Pfizer in 2013.


Distribution
History
Compensation Data Fiscal 2013 Ends: Dec 31
  • Salary$952,750
  • Stock Awards$1,529,600
  • Option Awards$1,542,325
  • Non-Equity Incentive$936,400
  • Other$159,666
  • Total$5,120,741
Company
Pfizer
Industry
Pharmaceuticals
Sector
Healthcare